QIAGEN Expands AI in NGS Software for Clinical Exome Completeness

QIAGEN announced  the expansion of its clinical decision support software, QIAGEN Clinical Insight Interpret (QCI Interpret), to include artificial in...

September 29, 2023 | Friday | News
Revvity Expands Access to Base Editing Technology With Aim to Accelerate Discovery to Cure

Launch of Pin-pointTM base editing reagents improves access to new-generation editing technology Access to the Pin-point system now bridges discovery, p...

September 27, 2023 | Wednesday | News
Alvotech Announces Approval in Japan of AVT04 (ustekinumab), a Biosimilar to Stelara®

“We are thrilled to receive marketing approval for AVT04 in Japan, which will be Alvotech’s second marketed biosimilar,” said Robert Wess...

September 26, 2023 | Tuesday | News
Qihan Biotech Completes Pre-Series B Financing for Stem Cell-Derived Cell Therapy in China

Hangzhou Qihan Biotech Co., Ltd. ("Qihan" or "Qihan Biotech" or "the Company"), an industry leader in applying multiplexable genome editing technology to c...

September 25, 2023 | Monday | News
European Commission Approves ORSERDU® for ER+ Breast Cancer with ESR1 Mutation

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

September 14, 2023 | Thursday | News
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced  that the European Unified Patent Court ("UPC") issued a...

September 20, 2023 | Wednesday | News
NTT and NCNP to Collaborate in Japan to Develop Brain Bio-Digital Twin Technology

News Highlights: Brain Bio-Digital Twin technology has the potential to change medical treatment practices by eliminating the need for invasive and cost...

September 15, 2023 | Friday | News
Natera Expands I-SPY 2 Collaboration for Signatera™ in Breast Cancer Neoadjuvant Study

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing,  announced a new study as part of the I-SPY 2 trial, sponsored and operated by ...

September 15, 2023 | Friday | News
Herophilus Announces Strategic Transaction with Genentech for Next-Generation Drug Discovery Platform

“Since our founding in 2017, Herophilus’s vision has been to leverage the parallel revolutions in human complex in vitro brain models, scaled l...

September 12, 2023 | Tuesday | News
Cell BioEngines Licenses Patent for Oncology Cell Transplantation

Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at Mount Sinai, in New ...

September 08, 2023 | Friday | News
NRx Pharmaceuticals' NRX-101 Shows Potent Antibacterial Activity Against Resistant Urinary Pathogens

NRX-101 demonstrated potent antibacterial effect against antibiotic-resistant pathogens in culture medium and in an artificial urine model D-cycloserine...

September 07, 2023 | Thursday | News
Zimmer Biomet India Launches Zimmer Biomet on Wheels Campaign

To launch the initiative Mandira Bedi, an actress, television presenter and a health & fitness icon, joined Zimmer Biomet Asia Pacific Group President ...

September 06, 2023 | Wednesday | News
The BioInnovation Institute welcomes eight new companies to its Venture Lab program

The 12-month Venture Lab program is designed to support start-up companies with business acceleration, scientific, and team development, and provides a fou...

September 04, 2023 | Monday | News
Exacta Bioscience and Ginkgo Bioworks Partner to Enhance Crop Protection Product

FitoRoot, a biostimulant product composed of three Bacillus strains, is designed to help crops better absorb water, nutrients and strengthen their defenses...

September 04, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close